The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue - Wikidata - awgldk - TriplyDB

The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue

The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue

http://www.wikidata.org/entity/Q24615008

about

Efficacy of psychostimulant drugs for amphetamine abuse or dependence Neuropharmacology of New Psychoactive Substances (NPS): Focus on the Rewarding and Reinforcing Properties of Cannabimimetics and Amphetamine-Like Stimulants Cathinone neurotoxicity ("The "3Ms")Psychoactive 'bath salts': compounds, mechanisms, and toxicities Effects of social interaction and warm ambient temperature on brain hyperthermia induced by the designer drugs methylone and MDPV.Agonist Medications for the Treatment of Cocaine Use Disorder Abuse-related effects of dual dopamine/serotonin releasers with varying potency to release norepinephrine in male rats and rhesus monkeys Pharmacological characterization of designer cathinones in vitro NPS: Medical Consequences Associated with Their Intake Substituted methcathinones differ in transporter and receptor interactions Effect of ambient temperature on the thermoregulatory and locomotor stimulant effects of 4-methylmethcathinone in Wistar and Sprague-Dawley rats Mephedrone in adolescent rats: residual memory impairment and acute but not lasting 5-HT depletion Dose and time-dependent selective neurotoxicity induced by mephedrone in mice The combined effects of 3,4-methylenedioxymethamphetamine (MDMA) and selected substituted methcathinones on measures of neurotoxicity Novel psychoactive substances: the pharmacology of stimulants and hallucinogens.Designer drugs 2015: assessment and management.The preclinical pharmacology of mephedrone; not just MDMA by another name.Monoamine transporter inhibitors and substrates as treatments for stimulant abuse Neurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamine In vivo effects of abused 'bath salt' constituent 3,4-methylenedioxypyrovalerone (MDPV) in mice: drug discrimination, thermoregulation, and locomotor activity.Intravenous self-administration of entactogen-class stimulants in male rats Cadherin 13: human cis-regulation and selectively-altered addiction phenotypes and cerebral cortical dopamine in knockout mice.Neuropharmacology of 3,4-Methylenedioxypyrovalerone (MDPV), Its Metabolites, and Related Analogs Mephedrone alters basal ganglia and limbic neurotensin systems.Use of synthetic cathinones and cannabimimetics among injection drug users in San Diego, California Characterization of a novel and potentially lethal designer drug (±)-cis-para-methyl-4-methylaminorex (4,4'-DMAR, or 'Serotoni').Pharmacology of novel synthetic stimulants structurally related to the "bath salts" constituent 3,4-methylenedioxypyrovalerone (MDPV).Locomotor stimulant and discriminative stimulus effects of 'bath salt' cathinones.Neurochemical profiles of some novel psychoactive substances Mephedrone and methylenedioxypyrovalerone (MDPV), major constituents of "bath salts," produce opposite effects at the human dopamine transporter Synthetic cathinones and their rewarding and reinforcing effects in rodents."Deconstruction" of the abused synthetic cathinone methylenedioxypyrovalerone (MDPV) and an examination of effects at the human dopamine transporter.Behavioral pharmacology of designer cathinones: a review of the preclinical literature Synthetic cathinones: chemical phylogeny, physiology, and neuropharmacology.Stereochemistry of mephedrone neuropharmacology: enantiomer-specific behavioural and neurochemical effects in rats 3,4-Methylenedioxypyrovalerone prevents while methylone enhances methamphetamine-induced damage to dopamine nerve endings: β-ketoamphetamine modulation of neurotoxicity by the dopamine transporter.Pharmacological profile of novel psychoactive benzofurans.The new stimulant designer compound pentedrone exhibits rewarding properties and affects dopaminergic activity.Baths salts, spice, and related designer drugs: the science behind the headlines.The new psychoactive substances 5-(2-aminopropyl)indole (5-IT) and 6-(2-aminopropyl)indole (6-IT) interact with monoamine transporters in brain tissue.

P2860

Q24198261-7851614C-7116-4BBE-82B2-6FED340D6167 Q26752739-E992CF09-6E62-46DE-9416-031B6214BCFD Q26828641-7BF8041F-ED13-45BF-B31F-7F322A9C1874 Q26830900-BE442D03-58ED-498E-BA29-697E743A43F7 Q27311250-067B8535-6BAE-4969-AE12-9F600F8B54AC Q28087404-26DCAC16-EB94-4047-BE8F-53A7E5C54477 Q28239471-3F412FBA-DC33-425D-868D-501ACB0987F6 Q28273207-18CEE8C0-8E2B-4AC3-8761-D4A8C975AF27 Q28276182-A4A0C1C7-2399-414B-B54C-D54C14E48B2E Q28288908-4BBAA735-BCE9-4902-997C-665A3E7FAF31 Q28483306-C88D558A-48D1-45A5-A780-D513996620A0 Q28483841-5EA45296-C35A-449A-B38F-23FC0758344E Q28539324-CE418E88-0B28-4C93-B0F2-DBF0D1D3518C Q28950585-9B7F6EB5-60C6-4133-8E49-D74DAD58B203 Q30251771-FEB0E4A8-575C-4F54-8263-2EBCD9D3EE15 Q30300017-9413BAAF-4BB1-4564-B173-8402C4D77654 Q30412911-755661C5-C76A-492B-8779-B2827811D43F Q30413718-53B151CB-914F-497D-B7D1-A1D74B3342B3 Q30417935-0F8D899F-D622-4E95-A475-7E506A85BF0F Q30535782-521A0E57-7CF7-44B1-9A39-ACE223BBE822 Q30680394-A80E9703-8650-4659-8170-10AFA593686F Q30826632-DF58E333-7165-48C2-9B7D-A1ED6E753548 Q33566201-079A77BD-4CA9-46B5-8337-A298C50A6C87 Q33934521-1E48A4BF-F7B9-4C73-8935-08745657D8A3 Q33968846-E81F6D39-E23D-4074-A863-EC8F965F84C4 Q34027074-A2F92441-6F7C-4FF5-B4B9-56A72F4B4A28 Q34122902-B7385D94-C286-4BE3-89C0-453D11305235 Q34280393-4E49D1A5-16A6-4A71-85E9-631DC5680D19 Q34319162-FF1FF068-AC96-4C51-99E6-CDF3D4CB0857 Q34325588-AA890F0C-A611-4FC9-888A-540030424EB7 Q34352354-0603316F-95C0-4F83-A9E2-80BB1C607C2B Q34377086-2C967C38-5C7E-4923-8079-2C4FA6D4B221 Q34385074-041B6DC3-65F5-41B4-9F0D-B6133A2FB4D6 Q34385110-C48BCA33-ED75-4990-A338-8192EB9991E2 Q34440487-DC7EDAC3-948C-4BB4-B7BB-FF5CB3F8363F Q34459984-27A3F164-561F-4881-9680-6493B7EB0E60 Q34466872-A4BCAC48-507F-436E-96E4-05A6F1C663C4 Q34490243-597B3DC2-6814-42D1-A274-54F57659E1E5 Q34491601-3A923B3B-BB36-45EE-952F-FBB4E469EC30 Q34493739-608DCB3F-9214-4992-9F9E-049FE230363B

P2860

The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue

http://www.wikidata.org/entity/Q24615008

description

2012 nî lūn-bûn

@nan

2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

The designer methcathinone ana ...... e transporters in brain tissue

@ast

The designer methcathinone ana ...... e transporters in brain tissue

@en

The designer methcathinone ana ...... e transporters in brain tissue

@nl

type

label

The designer methcathinone ana ...... e transporters in brain tissue

@ast

The designer methcathinone ana ...... e transporters in brain tissue

@en

The designer methcathinone ana ...... e transporters in brain tissue

@nl

prefLabel

The designer methcathinone ana ...... e transporters in brain tissue

@ast

The designer methcathinone ana ...... e transporters in brain tissue

@en

The designer methcathinone ana ...... e transporters in brain tissue

@nl

P1433

Q24615008-AF573D88-98C6-4133-8B08-D20060F410EA

P1476

Q24615008-47247940-BDCC-44DF-9E48-6E5670F386D7

P2093

Q24615008-1E475D5E-ABF7-41AA-8A98-7E98030A1C18

Q24615008-5409557A-CA92-4D89-BB56-BE7F94760F5E

Q24615008-7CE40480-D879-4248-82B3-005D17CF02F5

Q24615008-85934CDE-34A8-4DDE-8076-A967F649F1BB

Q24615008-A5A31140-E9BF-495D-8396-38E8969128EC

Q24615008-CA3E632E-231A-4349-91FA-9C372E381ABC

Q24615008-D971181F-6EF9-4900-9AF4-5CF40D3BB321

Q24615008-DB730712-ECDC-4081-9B5F-50E1765DDD27

Q24615008-EC605478-CC01-4F18-A198-B5869A0C7E3C

P2860

Q24615008-064C297C-AFB9-4536-89F4-05F643E75322

Q24615008-06580334-A0D8-489C-854A-05844F65B12D

Q24615008-1601318D-0F24-4F7D-8A35-F801EB9AB6C2

Q24615008-19C48FF8-4334-42E8-9CB3-CEBFBED97378

Q24615008-210BBA6D-7C27-4A01-8D57-55C48FE4C690

Q24615008-26D71BE0-B8F2-42F2-94E5-E196AF44BFF4

Q24615008-3C37CD03-7CD9-4A51-A69C-2877BC1EB541

Q24615008-3E2D1C0A-AA31-4CDE-BA5B-18E752104510

Q24615008-42FB7757-A0ED-4F87-AADE-AE6AD3E4F7DF

Q24615008-491CA4D9-84B7-4069-9991-DF06BC692DF0

P2888

Q24615008-E2CA67C7-C2D9-4D4A-B491-36B4EBF71F63

P304

Q24615008-9EE3E452-3E36-4EB6-8FE3-AD33629ECD84

P31

Q24615008-43D8781B-D46F-4748-B59C-66DAFEEC86B4

P3181

Q24615008-24E1BC35-1F64-432A-AA93-81AA8425114A

P356

Q24615008-1713D26D-FC87-49DF-97E6-641D33A3D1A1

P407

Q24615008-B70FD1CA-3D89-4CA0-AAF3-99078185A44C

P433

Q24615008-CDF0289F-256D-4E15-8E47-680183381578

P478

Q24615008-53D8E253-AA3A-4C69-9FBA-0F75245FAACC

P50

Q24615008-FF656299-62EF-4E3F-9BC5-8FC0E7A6B51F

P577

Q24615008-DFCCDE48-991F-4150-845E-EB0C9AB1C42D

P5875

Q24615008-88DA9FD1-17B2-439E-B175-3DC5C5159269

P6179

Q24615008-441F9AC1-BAA3-4DAD-A4A5-F254D52C23C3

P698

Q24615008-A48C278C-A4FE-454A-9813-C3528323B0F5

P921

Q24615008-6C0497CD-ECAD-4FA9-A2EA-CE1672D0141D

P932

Q24615008-517344EB-57A5-4B2C-A258-892A562B20E1

P3181

P356

P1433

Neuropsychopharmacology

P1476

The designer methcathinone ana ...... e transporters in brain tissue

@en

P2093

Alexander T Shulgin

http://www.w3.org/2001/XMLSchema#string

Arnold E Ruoho

http://www.w3.org/2001/XMLSchema#string

Jacqueline R Sink

http://www.w3.org/2001/XMLSchema#string

John S Partilla

http://www.w3.org/2001/XMLSchema#string

Mario A Ayestas

http://www.w3.org/2001/XMLSchema#string

Michael H Baumann

http://www.w3.org/2001/XMLSchema#string

Nicholas V Cozzi

http://www.w3.org/2001/XMLSchema#string

Paul F Daley

http://www.w3.org/2001/XMLSchema#string

Richard B Rothman

http://www.w3.org/2001/XMLSchema#string

P2860

Dopamine and reward: The anhedonia hypothesis 30 years on

Mephedrone, compared with MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and 5-HT levels in nucleus accumbens of awake rats

Clinical characteristics of mephedrone toxicity reported to the U.K. National Poisons Information Service

Recreational use of mephedrone (4-methylmethcathinone, 4-MMC) with associated sympathomimetic toxicity

In vivo effects of amphetamine analogs reveal evidence for serotonergic inhibition of mesolimbic dopamine transmission in the rat

4-Methylmethcathinone (mephedrone): neuropharmacological effects of a designer stimulant of abuse

1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors

Evidence for the involvement of dopamine transporters in behavioral stimulant effects of modafinil

Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin

Inhibition of plasma membrane monoamine transporters by beta-ketoamphetamines

P2888

P304

1192-1203

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1738082

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/NPP.2011.304

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

37

http://www.w3.org/2001/XMLSchema#string

P50

Simon D. Brandt

P577

2011-12-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232749512

http://www.w3.org/2001/XMLSchema#string

P6179

1044856319

http://www.w3.org/2001/XMLSchema#string

P698

22169943

http://www.w3.org/2001/XMLSchema#string

P921

P932

3306880

http://www.w3.org/2001/XMLSchema#string